JP2009541409A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009541409A5 JP2009541409A5 JP2009517063A JP2009517063A JP2009541409A5 JP 2009541409 A5 JP2009541409 A5 JP 2009541409A5 JP 2009517063 A JP2009517063 A JP 2009517063A JP 2009517063 A JP2009517063 A JP 2009517063A JP 2009541409 A5 JP2009541409 A5 JP 2009541409A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament
- medicament according
- mammal
- defibrotide
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 10
- 241000124008 Mammalia Species 0.000 claims 2
- JNWFIPVDEINBAI-UHFFFAOYSA-N [5-hydroxy-4-[4-(1-methylindol-5-yl)-5-oxo-1H-1,2,4-triazol-3-yl]-2-propan-2-ylphenyl] dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C(C(C)C)=CC(C=2N(C(=O)NN=2)C=2C=C3C=CN(C)C3=CC=2)=C1O JNWFIPVDEINBAI-UHFFFAOYSA-N 0.000 claims 2
- 229960004120 defibrotide Drugs 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000007900 aqueous suspension Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06425436A EP1872787A1 (en) | 2006-06-27 | 2006-06-27 | Use of defibrotide for the inhibition of heparanase |
| PCT/EP2007/054633 WO2008000549A1 (en) | 2006-06-27 | 2007-05-14 | Use of defibrotide for the inhibition of heparanase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009541409A JP2009541409A (ja) | 2009-11-26 |
| JP2009541409A5 true JP2009541409A5 (enExample) | 2010-06-17 |
Family
ID=37496823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009517063A Pending JP2009541409A (ja) | 2006-06-27 | 2007-05-14 | ヘパラナーゼの抑制の為にデフィブロチドを使用する方法。 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20090131362A1 (enExample) |
| EP (2) | EP1872787A1 (enExample) |
| JP (1) | JP2009541409A (enExample) |
| CA (1) | CA2655522A1 (enExample) |
| IL (1) | IL195971A0 (enExample) |
| WO (1) | WO2008000549A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20031714A1 (it) | 2003-09-05 | 2005-03-06 | Gentium Spa | Formazioni ad azione antitumorale. |
| EP1982722A1 (en) * | 2007-04-16 | 2008-10-22 | Gentium S.p.A. | Use of oligotide for the treatment of renal diseases |
| JP6069209B2 (ja) | 2010-11-12 | 2017-02-01 | ジェンティウム ソシエタ ア レスポンサビリタ リミタータ | 移植片対宿主病（ｇｖｈｄ）の予防および／または治療に使用するためのデフィブロタイド |
| JP6198821B2 (ja) | 2012-06-22 | 2017-09-20 | ゲンチウム エス．アール．エル． | デフィブロチドの生物学的活性を決定する為の、ユーグロブリンに基づく方法 |
| EP3026122A1 (en) | 2014-11-27 | 2016-06-01 | Gentium S.p.A. | Cellular-based method for determining the potency of defibrotide |
| MX2020001337A (es) | 2017-08-03 | 2020-09-09 | Jazz Pharmaceuticals Ireland Ltd | Formulaciones que comprenden un acido nucleico en una alta concentracion. |
| MX2020010689A (es) | 2018-04-12 | 2021-01-20 | Jazz Pharmaceuticals Inc | Defibrotida para la prevencion y tratamiento del sindrome de liberacion de citocinas y la neurotoxicidad asociada con la inmunodeplecion. |
| US20220023533A1 (en) | 2018-12-07 | 2022-01-27 | Jazz Phrmaceticals Ireland Limited | Subcutaneous delivery of high concentration formulations |
| WO2021174039A1 (en) | 2020-02-28 | 2021-09-02 | Jazz Pharmaceuticals Ireland Limited | Delivery of low viscosity formulations |
| WO2022234101A1 (en) | 2021-05-06 | 2022-11-10 | Jazz Pharmaceuticals Ireland Limited | Defibrotide for the treatment and prevention of acute respiratory distress syndrome |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2154279A1 (de) * | 1970-11-03 | 1972-05-25 | Crinos Industria Farmaco | Medikamente für das fibrinolytische System |
| IT1043823B (it) * | 1970-11-03 | 1980-02-29 | Prephar | Procedimento per l estrazione di acidi nucleici da organi animali |
| US3899481A (en) * | 1970-11-03 | 1975-08-12 | Crinos Industria Farmaco | Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs |
| US4853221A (en) * | 1980-11-13 | 1989-08-01 | Warner-Lambert Company | Method for treating non-small cell lung cancer, head and neck cancers and breast cancer |
| IT1170215B (it) * | 1983-09-12 | 1987-06-03 | Crinos Industria Farmaco | Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta |
| IT1170214B (it) * | 1983-09-12 | 1987-06-03 | Crinos Industria Farmaco | Composizione farmaceutica per la cura delle arteriopatie periferiche |
| IT1206341B (it) * | 1984-02-16 | 1989-04-14 | Crinos Industria Farmaco | Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio. |
| US4694134A (en) * | 1985-05-28 | 1987-09-15 | Ajax Magnethermic Corporation | Apparatus for overheating edges of skelp for the production of compression welded pipe |
| US5223609A (en) * | 1986-04-17 | 1993-06-29 | Crinos Industria Farmacobiologica S.P.A. | Process for obtaining chemically defined and reproducible polydeoxyribonucleotides |
| US4753221A (en) * | 1986-10-22 | 1988-06-28 | Intravascular Surgical Instruments, Inc. | Blood pumping catheter and method of use |
| IT1231509B (it) * | 1989-09-07 | 1991-12-07 | Crinos Industria Farmaco | Composizione farmceutica ad uso topico per la terapia della fragilita' capillare. |
| FR2654271B1 (fr) * | 1989-11-06 | 1992-01-24 | Moving Magnet Tech | Actionneur electromagnetique monophase angulaire. |
| US6699985B2 (en) * | 1991-08-21 | 2004-03-02 | Arsinur Burcoglu | Method of treating HIV infection and related secondary infections thereof |
| US5624912A (en) * | 1991-08-21 | 1997-04-29 | Burcoglu; Arsinur | Method of treating HIV infection and related secondary infections with defibrotide |
| US5977083A (en) * | 1991-08-21 | 1999-11-02 | Burcoglu; Arsinur | Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states |
| IT1252174B (it) * | 1991-12-09 | 1995-06-05 | Crinos Industria Farmaco | Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento |
| US5578716A (en) * | 1993-12-01 | 1996-11-26 | Mcgill University | DNA methyltransferase antisense oligonucleotides |
| DE69928778T2 (de) * | 1999-06-08 | 2006-07-06 | Gentium S.P.A., Villa Guardia | Anwendung von Komplexen von kationischen Liposomen und Polydeoxyribonukleotiden wie Arzneimitteln |
| US20070037144A1 (en) * | 2000-10-20 | 2007-02-15 | Jay Wohlgemuth | Leukocyte expression profiling |
| SE0003912D0 (sv) * | 2000-10-24 | 2000-10-24 | Abb Ab | Industrirobot |
| US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| WO2003027313A2 (en) * | 2001-09-24 | 2003-04-03 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE |
| US6965025B2 (en) * | 2001-12-10 | 2005-11-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of connective tissue growth factor expression |
| EP1325962A1 (en) * | 2001-12-17 | 2003-07-09 | Gentium S.p.A. | A method for determining the biological activity of defibrotide |
| KR100509057B1 (ko) * | 2002-10-23 | 2005-08-18 | 엘지전자 주식회사 | 진공청소기용 흡입노즐 |
| ITMI20031714A1 (it) * | 2003-09-05 | 2005-03-06 | Gentium Spa | Formazioni ad azione antitumorale. |
-
2006
- 2006-06-27 EP EP06425436A patent/EP1872787A1/en not_active Withdrawn
-
2007
- 2007-05-14 US US12/305,219 patent/US20090131362A1/en not_active Abandoned
- 2007-05-14 WO PCT/EP2007/054633 patent/WO2008000549A1/en not_active Ceased
- 2007-05-14 JP JP2009517063A patent/JP2009541409A/ja active Pending
- 2007-05-14 CA CA002655522A patent/CA2655522A1/en not_active Abandoned
- 2007-05-14 EP EP07729085A patent/EP2035013A1/en not_active Withdrawn
-
2008
- 2008-12-16 IL IL195971A patent/IL195971A0/en unknown
-
2015
- 2015-01-20 US US14/600,680 patent/US20150196580A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009541409A5 (enExample) | ||
| JP2009537554A5 (enExample) | ||
| IL259851A (en) | Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders | |
| JP2016053040A5 (enExample) | ||
| JP2012502037A5 (enExample) | ||
| JP2010522242A5 (enExample) | ||
| JP2016163571A5 (enExample) | ||
| NZ586751A (en) | Use of CDDO methyl ester (methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate) for the treatment of renal diseases and for improving kigney function | |
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| JP2010504973A5 (enExample) | ||
| JP2014518860A5 (enExample) | ||
| JP2010536849A5 (enExample) | ||
| ECSP10010052A (es) | Formulaciones galenicas de alisquireno y valsartan | |
| PE20060588A1 (es) | Composiciones farmaceuticas que contienen flibanserina | |
| JP2009538898A5 (enExample) | ||
| HRP20151091T1 (hr) | UPORABA 24-norUDCA | |
| JP2015537009A5 (enExample) | ||
| JP2013166781A5 (enExample) | ||
| JP2014221827A5 (enExample) | ||
| JP2008513510A5 (enExample) | ||
| HRP20211046T1 (hr) | Upotreba derivata benzimidazola kod noćnog proboja kiseline | |
| NZ593199A (en) | Milnacipran for the long-term treatment of fybromyalgia syndrome | |
| WO2017182873A3 (en) | Peptide-oligourea foldamer compounds and methods of their use | |
| JP2011520980A5 (enExample) | ||
| RU2016112257A (ru) | Композиция для лечения гипертензии и/или фиброза |